OXTR and adenomyosis: Additionally, subgroup analysis based on adenomyosis types revealed significantly higher clinical pregnancy rates, ongoing pregnancy rates and live birth rates in the group receiving oxytocin receptor antagonists compared to the control group among women diagnosed with diffuse adenomyosis.